NDC 0061-5432 - Mometamax Single
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-5432
- Package NDCs from labels
- 0061-5432-01
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2025-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| gentamicin, posaconazole, and mometasone furoate otic suspension | Merck Sharp & Dohme Corp. | 2025-05-06 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-5432-01 | Mometamax Single | 1 in 1 CARTON | SUSPENSION | 1 | 1 | |
| 0061-5432-01 | Mometamax Single | 24 mL in 1 BOTTLE, DISPENSING | SUSPENSION | 24 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 3532bb39-a1a6-9d67-e063-6294a90abc0c | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 5193ed8d-44c9-46fe-924d-93aaea922cfd | 2025-05-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Posaconazole | POSACONAZOLE | A2A Integrated Pharmaceuticals | 4d14ceab-196e-4dc3-8b21-5c4629ada161 | 2025-02-28 | Warnings, Adverse reactions | 6TK1G07BHZ |
| POSACONAZOLE | POSACONAZOLE | Golden State Medical Supply, Inc. | e883b495-d7e7-6d58-e053-2a95a90a1cd3 | 2025-02-24 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 0bef2a01-69d0-cf50-e063-6294a90a4c52 | 2025-02-03 | Warnings, Adverse reactions | 8X7386QRLV |
| POSACONAZOLE | POSACONAZOLE | Camber Pharmaceuticals, Inc. | c551e121-d5fc-4b35-ba9f-72ce3a314fdc | 2025-01-31 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Posaconazole | POSACONAZOLE | AvPAK | de95df83-a495-1900-e053-2995a90abf24 | 2025-01-09 | Warnings, Adverse reactions | 6TK1G07BHZ |
| POSACONAZOLE | POSACONAZOLE | Lannett Company Inc. | 94a9b028-a2bc-4f41-884d-2d6c536881fc | 2024-12-03 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Posaconazole | POSACONAZOLE | i3 Pharmaceuticals, LLC | d5300d14-219d-4e1e-bfac-b413c40d6e3a | 2024-11-29 | Warnings, Adverse reactions | 6TK1G07BHZ |
| MOMETASONE FUROATE | MOMETASONE FUROATE | Aurohealth LLC | 48ba8c52-73b6-4ee9-ba13-756a645a9183 | 2024-11-25 | Warnings | MTW0WEG809 |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | 63413469-c676-48a3-a945-7d2489b535ef | 2024-10-14 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 84f5c763-1cd3-4d85-9afb-934db8666fbf | 2024-10-11 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| posaconazole | POSACONAZOLE | Novadoz Pharmaceuticals LLC | 0bdf77ae-3639-49c1-b7c7-533f9d073084 | 2024-09-25 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals, Inc. | 4add8f7b-48f0-6b6a-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Bausch & Lomb Incorporated | 41d01350-5c4b-42fc-be5f-986ceec02bd3 | 2024-07-22 | Warnings, Adverse reactions | 8X7386QRLV |
| Posaconazole | POSACONAZOLE | Bryant Ranch Prepack | d2daba09-f1c2-4764-a567-1291be4892b9 | 2024-07-16 | Warnings, Adverse reactions | 6TK1G07BHZ |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 82595309-304e-a221-e053-2991aa0ac0a9 | 2024-06-14 | Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 85424b40-5c2d-421d-e053-2991aa0a7771 | 2024-06-14 | Warnings, Adverse reactions | 8X7386QRLV |
| MOMETASONE FUROATE MONOHYDRATE | MOMETASONE FUROATE MONOHYDRATE | Aurobindo Pharma Limited | b24f80c5-afe2-4821-9185-2dad3cfe277a | 2024-03-19 | Warnings, Adverse reactions | MTW0WEG809 |
| GENTAMICIN | GENTAMICIN | HF Acquisition Co LLC, DBA HealthFirst | c1ff0cdc-ac5d-30ca-e053-2a95a90a5066 | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.